JP2012507521A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012507521A5 JP2012507521A5 JP2011534525A JP2011534525A JP2012507521A5 JP 2012507521 A5 JP2012507521 A5 JP 2012507521A5 JP 2011534525 A JP2011534525 A JP 2011534525A JP 2011534525 A JP2011534525 A JP 2011534525A JP 2012507521 A5 JP2012507521 A5 JP 2012507521A5
- Authority
- JP
- Japan
- Prior art keywords
- difficile
- group
- composition
- acyl
- con
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C[C@](CC*)[C@@](CC1)[C@@](C)(CC2)[C@]1[C@@]1[C@]2[C@@](C)(CCC(*)C2)[C@]2CC1* Chemical compound C[C@](CC*)[C@@](CC1)[C@@](C)(CC2)[C@]1[C@@]1[C@]2[C@@](C)(CCC(*)C2)[C@]2CC1* 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11074708P | 2008-11-03 | 2008-11-03 | |
| US61/110,747 | 2008-11-03 | ||
| US12283508P | 2008-12-16 | 2008-12-16 | |
| US61/122,835 | 2008-12-16 | ||
| US15013609P | 2009-02-05 | 2009-02-05 | |
| US61/150,136 | 2009-02-05 | ||
| PCT/US2009/005929 WO2010062369A2 (en) | 2008-11-03 | 2009-11-02 | Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012507521A JP2012507521A (ja) | 2012-03-29 |
| JP2012507521A5 true JP2012507521A5 (enExample) | 2012-12-13 |
| JP5620392B2 JP5620392B2 (ja) | 2014-11-05 |
Family
ID=42226300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011534525A Expired - Fee Related JP5620392B2 (ja) | 2008-11-03 | 2009-11-02 | クロストリジウム・ディフィシレ胞子の発芽および伸長を阻害するための方法および組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9340569B2 (enExample) |
| EP (1) | EP2367839A4 (enExample) |
| JP (1) | JP5620392B2 (enExample) |
| AU (1) | AU2009320350B2 (enExample) |
| CA (1) | CA2779413A1 (enExample) |
| WO (1) | WO2010062369A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9079935B2 (en) | 2012-08-13 | 2015-07-14 | The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas | Reducing risk of contracting Clostridium-difficile associated disease |
| US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| NZ709392A (en) | 2012-11-23 | 2016-10-28 | Seres Therapeutics Inc | Synergistic bacterial compositions and methods of production and use thereof |
| EP3904502A3 (en) | 2013-02-04 | 2022-02-23 | Seres Therapeutics, Inc. | Compositions and methods |
| US11185562B2 (en) | 2013-02-04 | 2021-11-30 | Seres Therapeutics, Inc. | Compositions and methods for inhibition of pathogenic bacterial growth |
| HK1220326A1 (zh) | 2013-03-15 | 2017-05-05 | Seres Therapeutics, Inc. | 基於网络微生物组成和方法 |
| WO2015076788A1 (en) | 2013-11-19 | 2015-05-28 | The Texas A&M University System | Muricholic acid-based compounds as inhibitors of clostridium difficile spore germination |
| MX367109B (es) | 2013-11-25 | 2019-08-05 | Seres Therapeutics Inc | Composiciones bacterianas sinergicas y sus metodos de produccion y usos. |
| WO2015095241A2 (en) | 2013-12-16 | 2015-06-25 | Seres Health, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
| EP4527400A3 (en) * | 2014-05-19 | 2025-06-11 | Memorial Sloan Kettering Cancer Center | Methods and compositions for reducing clostridium difficile infection |
| GB201421071D0 (en) * | 2014-11-27 | 2015-01-14 | Univ Aston | Compound for treating clostridium difficile |
| WO2016127102A2 (en) | 2015-02-06 | 2016-08-11 | Ernesto Abel-Santos | Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis |
| IL298281A (en) | 2015-11-03 | 2023-01-01 | Brigham & Womens Hospital Inc | Medical microbiota for the treatment and/or prevention of food allergy |
| MX2018012060A (es) * | 2016-04-05 | 2019-03-06 | Nch Corp | Composicion rica en nutriente germinante y metodo de incubacion de esporas. |
| AU2018318132B2 (en) | 2017-08-14 | 2025-06-26 | Seres Therapeutics, Inc. | Compositions and methods for treating cholestatic disease |
| KR102323783B1 (ko) * | 2017-09-22 | 2021-11-09 | 주식회사 고바이오랩 | 클로스트리디움 디피실레(Clostridium difficile) 성장 억제효과를 갖는 클로스트리디움 신덴스 균주 |
| EP3703720A1 (en) | 2017-10-30 | 2020-09-09 | Seres Therapeutics, Inc. | Compositions and methods for treating antibiotic resistance |
| AR115921A1 (es) | 2018-08-10 | 2021-03-10 | Phenex Pharmaceuticals Ag | Ácido isolitocólico o ácido isoalolitocólico y derivados deuterados de los mismos para prevenir y tratar enfermedades asociadas a clostridium difficile |
| CA3109900A1 (en) | 2018-08-17 | 2020-02-20 | Universidad Andres Bello | Method and pharmacological composition for the prevention of recurrent infections caused by clostridium difficile |
| WO2020260558A1 (en) | 2019-06-27 | 2020-12-30 | Phenex Pharmaceuticals Ag | 3-modified iso-/isoallo-lithocholic acid derivatives or their homo-analogs for preventing and treating clostridioides difficile-associated diseases |
| US20230146782A1 (en) * | 2019-08-06 | 2023-05-11 | Du Jessica Xinyun | Deoxycholic acid compounds, pharmaceutical compositions and uses thereof |
| AU2021207019A1 (en) * | 2020-01-16 | 2022-09-01 | Jsr Corporation | Composition for producing bile acids |
| WO2021163212A1 (en) | 2020-02-10 | 2021-08-19 | Native Microbials, Inc. | Microbial compositions and methods of use for canine enteropathy and dysbiosis |
| US12220421B2 (en) | 2021-09-09 | 2025-02-11 | The Boards Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las | Inhibitors of C. difficile spore germination |
| WO2023079335A1 (en) | 2021-11-03 | 2023-05-11 | Universidad Andrés Bello | Composition based on nystatin and vancomycin nanoparticles for the treatment of clostridioides difficile infection and prevention of recurrence |
| WO2023105494A1 (en) | 2021-12-10 | 2023-06-15 | Universidade Do Porto | Cationic steroid compounds, method of obtaining thereof, formulations comprising thereof and their uses |
| CN120905091A (zh) * | 2025-09-30 | 2025-11-07 | 北京常友生物科技有限公司 | 大肠埃希氏菌yc49及其协同拟杆菌在抑制艰难梭菌中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3708510A (en) * | 1970-09-03 | 1973-01-02 | Merck & Co Inc | Amides of cholanic acid,cholenic acid,and choladienic acid |
| JPS62175497A (ja) * | 1986-01-28 | 1987-08-01 | Wakunaga Pharmaceut Co Ltd | 胆汁酸誘導体およびその製造法 |
| JPH0749438B2 (ja) * | 1990-10-31 | 1995-05-31 | 東京田辺製薬株式会社 | タウリン抱合型胆汁酸の精製方法 |
| DE19645044A1 (de) * | 1996-10-31 | 1998-05-07 | Falk Pharma Gmbh | Verwendung von Ursodeoxycholsäure zur topischen Behandlung von Entzündungserkrankungen der Schleimhäute |
| IL123998A (en) | 1998-04-08 | 2004-09-27 | Galmed Int Ltd | Conjugates of bile salts and pharmaceutical preparations containing them |
| US6326364B1 (en) * | 1999-02-08 | 2001-12-04 | Cedars-Sinai Medical Center | Use of 5-aminosalicylates as antimicrobial agents |
| US7247299B2 (en) | 2002-11-27 | 2007-07-24 | Kemin Industries, Inc. | Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens |
| US20090131384A1 (en) * | 2006-03-22 | 2009-05-21 | Syndexa Pharmaceuticals Corporation | Compounds and methods for treatment of disorders associated with er stress |
| US20080254010A1 (en) | 2007-03-12 | 2008-10-16 | Joseph Myron Sasser | Controlling Clostridium difficile-Associated Disease in the Gastrointestinal Tract |
-
2009
- 2009-11-02 US US13/126,687 patent/US9340569B2/en not_active Expired - Fee Related
- 2009-11-02 WO PCT/US2009/005929 patent/WO2010062369A2/en not_active Ceased
- 2009-11-02 AU AU2009320350A patent/AU2009320350B2/en not_active Ceased
- 2009-11-02 JP JP2011534525A patent/JP5620392B2/ja not_active Expired - Fee Related
- 2009-11-02 EP EP09829458A patent/EP2367839A4/en not_active Withdrawn
- 2009-11-02 CA CA2779413A patent/CA2779413A1/en not_active Abandoned
-
2016
- 2016-04-20 US US15/133,437 patent/US20170056419A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010007375A (es) | Nuevos derivados de lupano. | |
| JP2021524476A5 (enExample) | ||
| RU2011136250A (ru) | Низкомолекулярное полисульфатированное производное гиалуроновой кислоты и содержащее его лекарственное средство | |
| MX2022010811A (es) | Tratamiento de la diabetes tipo 2 u obesidad o sobrepeso con el acido 2-[(4-{6-[(4-ciano-2-fluorobencil)oxi]piridin-2-il}piperidin -1-il)metil]-1-[(2s)-oxetan-2-ilmetil]-1h-bencimidazol-6-carboxil ico o una sal farmaceutica del mismo. | |
| JP2006182786A5 (enExample) | ||
| NZ700195A (en) | Compositions comprising deoxycholic acid | |
| JP2012530758A5 (enExample) | ||
| JP2013541514A5 (enExample) | ||
| WO2009082818A8 (en) | Novel c-21-keto lupane derivatives preparation and use thereof | |
| JP2013542223A5 (enExample) | ||
| EP2355810B1 (en) | Compound for the treatment of psoriasis | |
| WO2006009092A1 (ja) | 効果的な医薬の使用法及び副作用発現の防御に関する方法 | |
| JP2011527345A5 (enExample) | ||
| RU2478385C2 (ru) | Соединения триазола для лечения образования биопленок | |
| MX2014009640A (es) | Metodos de tratamientos de fibrosis. | |
| JP2015508068A5 (enExample) | ||
| NO20092539L (no) | Antibakterielle kinolin-derivater | |
| JP2015531376A5 (enExample) | ||
| JP2012523458A5 (enExample) | ||
| AU2024205783A1 (en) | Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use | |
| JP2013532714A5 (enExample) | ||
| JP2012504584A5 (enExample) | ||
| JP7125350B2 (ja) | ラクトース不耐性を処置する方法 | |
| JP2018507880A5 (enExample) | ||
| CN102223883B (zh) | 用于治疗抑郁症、焦虑症、精神分裂症、睡眠障碍和癫痫症的琥珀酸的胆碱盐 |